Resultados de la búsqueda 571-580 of 21719 for Cancer Awareness
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...
... cancer (from blood and tissue samples) to improve the overall accuracy of diagnosis and effectiveness of cancer treatment. Innovative Trial for Understanding ...
The aim of this study is to develop a feasible, acceptable, and sustainable comprehensive cancer distress management program that is tailored to the unique ...
Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...
Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...
The purpose of this study is to assemble a collection of serial plasma biospecimens from women with ovarian, primary peritoneal, or fallopian tube cancer ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a histopathologic ...
, Cáncer de la uretra, Cáncer de mama, Cáncer de endometrio, Cáncer cervical ... Understanding triple-negative breast cancer and its treatment Jan. 04, 2024 ...
... cancer and the body's response to cancer and related treatments. ... cancers, and may undergo ... understanding of unmet needs, social support, and distress.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?